首页> Pharmacoepidemiology and drug safety> Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection.

Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection.

导出原文传递

翻译打印收藏纠错

第一作者： Nhung T H,Trinh

第一单位： Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Research Center for Epidemiology and Biostatistics Sorbonne Paris Cité (CRESS), Paris Descartes University, Paris, France.;Adverse Events and incidents Department-Surveillance Division, Agence nationale de sécurité du médicament et des produits de santé (ANSM), Saint Denis, France.

作者： Nhung T H,Trinh ^[1] ; Elodie,Solé ^[2] ; Mehdi,Benkebil ^[2]

作者单位： Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Research Center for Epidemiology and Biostatistics Sorbonne Paris Cité (CRESS), Paris Descartes University, Paris, France.;Adverse Events and incidents Department-Surveillance Division, Agence nationale de sécurité du médicament et des produits de santé (ANSM), Saint Denis, France. ^[1] Adverse Events and incidents Department-Surveillance Division, Agence nationale de sécurité du médicament et des produits de santé (ANSM), Saint Denis, France. ^[2]

关键词 change-point analysis disproportionality analysis pharmacoepidemiology pharmacovigilance proportional reporting ratio signal detection